Share Email Print
cover

Proceedings Paper

Studies of photosensitizers from the phthalocyanine family in the perspective of two-photon photodynamic therapy
Author(s): Michel Fournier
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Photodynamic therapy (PDT) of cancer is a treatment with strengths and weaknesses. Amongst the latter is the need for the presence of oxygen for the photodynamic effect to occur. It is a known fact that singlet oxygen, generated from the first triplet excited state (T1) of the photosensitizer, is responsible for the lethal photodynamic effect [1, 2, 3, 4]. The problem lies in the lack of oxygen in the core of a tumor. It seems that the excited triplet state energy of the photosensitizers currently in use in PDT lies below the threshold of a lethal anoxic chemical reaction.

Paper Details

Date Published: 29 August 2017
PDF: 3 pages
Proc. SPIE 10313, Opto-Canada: SPIE Regional Meeting on Optoelectronics, Photonics, and Imaging, 1031338 (29 August 2017); doi: 10.1117/12.2283912
Show Author Affiliations
Michel Fournier, Univ. de Sherbrooke (Canada)


Published in SPIE Proceedings Vol. 10313:
Opto-Canada: SPIE Regional Meeting on Optoelectronics, Photonics, and Imaging
John C. Armitage, Editor(s)

© SPIE. Terms of Use
Back to Top